RUBICON

Rubicon Research Limited

Healthcare

Share price

₹1,597

Market cap

₹26,440 Cr

1Y return

▲ 154%

A pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated drug formulations across multiple therapeutic areas. Incorporated in 1999, the company specializes in creating specialized formulations that address specific medical needs in the Indian healthcare market. Its integrated operations span research and development, manufacturing of quality pharmaceuticals, and distribution. The company distinguishes itself through its focus on bringing innovative, differentiated solutions to patients and healthcare providers.

Investors holding Rubicon Research Limited

Amansa Holdings

Foreign Investor

3.12%

Foreign Investor

1.42%

Foreign Investor

1.35%

Recent moves 16

Moves16

GIRISH SUBRAMANIAM IYER

8 Sept 2026. Sign in to see this move

General Atlantic Singapore RR Pte. LtdDecreased

Promoter General Atlantic Singapore RR Pte. Ltd. sold 1.4 crore shares of Rubicon Research on the open market, trimming its stake from 35.45% to 27.07%.

General Atlantic Singapore RR Pte LtdDecreased

General Atlantic Singapore RR Pte Ltd, a promoter of Rubicon Research Limited, sold 1.4 crore shares for ₹2325.03 Cr at ₹1660.73 apiece in a market sale, decreasing its stake from 35.79% to 27.34%.

Aranda Investments

26 Aug 2026. Sign in to see this move

26 Aug 2026. Sign in to see this move

26 Aug 2026. Sign in to see this move

Axis Mutual FundNew position

Axis Mutual Fund bought 903,611 shares of Rubicon Research Limited for ₹150.00 Cr at ₹1660.00 apiece in a block deal.

NomuraIncreased

Nomura bought 1,203,999 shares of Rubicon Research Limited for ₹199.86 Cr at ₹1660.00 apiece in a block deal.

SBI Mutual FundNew position

SBI Mutual Fund bought 1,204,815 shares of Rubicon Research Limited for ₹200.00 Cr at ₹1660.00 apiece in a block deal on August 26, 2026. This transaction was part of broader block deal activity in Rubicon Research on this date.

Kotak Mutual FundNew position

Kotak Mutual Fund bought 1,656,624 shares of Rubicon Research Limited in a block deal for ₹275.00 Cr at ₹1660.00 apiece on August 26, 2026.

Track the whales in Rubicon Research Limited

Get alerted the moment a top investor buys or sells.